ISSN: 2161-0517
Teresa L Singleton
Ndohnui Noel
Role of APOBEC3B deletion and IL16 promoter polymorphism and its association with HIV susceptibility
Kavita Kakkar1, Sanjukta Vidyant1, Anurag Rathore2, Animesh Chatterjee3, Nikky Nyari1, Swati Sharma1, Sayali Mukherjee4, Vikas Agarwal1 and T N Dhole1
Characterization of asymptomatic children infected with the human immunodeficiency virus at birth
Celine Nguefeu Nkenfou1,2, Edith Saounde Temgoua1,3, Béatrice Dambaya1,2, Charlotte Tanguinpundum1, Vittorio Colizzi3 and Jacques theze4
Belayneh Hamdela, Fregenet Zekiewos and Tigist Workneh
Structure-Based Design of Dual inhibitors of HIV Integrase and Ribonuclease H
Sonali Kurup1, Sinni Jacob1and Sudhir Raghavan2
Evaluation of the effect of c.2946+1G>T mutation on splicing in the SCN1A gene
Afif Ben Mahmoud1, Riadh Ben Mansour2, Fatma Driss3 and Faiza Fakhfakh1
Ana Carolina Viegas Carmo1,2,4, Dalton Nogueira da Silva Giovanni3,4, Mariana Tonelotto4, Nathalia Delazeri de Carvalho4, Karina Senna Villar4, Fernando Luiz Kamitani4, Kamilla Alves Carvalho5, Erika Ohta Watanabe5, Fabiana Regina Xavier Batista5, Darci Moraes Barros-Battesti6 and Ronaldo Zucatell
Florence Kinyua1,2, Michael Kiptoo1,2, Gideon Kikuvi2, Joseph Mutai1, Peter Muiruri+ and Elijah Songok1,2
New targets for drug development against HIV-1
B Sharma and Shweta Singh
Caroline Leroux1, Margaux Monot1, Alexandra Erny1, Barbara Gineys1, Sophie Desloire1, Christine Dolmazon1, Anne Aublin-Gex2, Vincent Lotteau2 and Fabienne Archer1
Feleke Doyore
Antiviral compounds from marine natural product
Chang Yih Duh
Fregenet Zekiewos
Gebrehiwot Teklay, Befikadu Legesse and Mebratu Legesse
Jacques Leibowitch1, Dominique Mathez1, Pierre de Truchis1, Damien Ledu1, Jean Claude melchior1, Guislaine Carcelain2, Jacques Izopet3, Christian Perronne1 and John R David4
Kidane Tadesse and Fisaha Haile
Signal peptide-binding drug as a selective CD4 receptor down-modulator with anti-HIVactivity
Kurt Vermeire
Lucina Koyio
Attacking HIV-1 reservoirs with viral mutagens
Luise Mansky
M Sanou1,2,3, S T Soubeiga1,5, O Yacouba2,3, F Bationo4, T R Compaore1, T M Zohoncon1,5, G N Diatto2, P Ouedraogo5, B M Nagalo1,6, C Bisseye1, R Ouedraogo/Traore3 and J Simpore1,5
HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemia
Franck Mortreux1, Morgan Thénoz1, Celine Vernin1, Hussein Mortada2, Maroun Karam1, Christiane Pinatel2, Antoine Gessain3, Thomas R Webb4, Didier Auboeuf2 and Eric Wattel1
Ahani N
Nelida Gomez
Philipos Petros
Rafael Correa Rocha
Small molecule compounds inhibit Vpu mediated down-regulation BST-2
Shan Cen, Zeyun Mi, Quan Zhang, Jinming Zhou, Xiaoyu Li and Jiwei Ding
A novel “priming-boosting” strategy for immune interventions in cervical cancer
Mrs shujie
Empathetic social context of HIV researches and treatment: The core of long term success
Stephen Talugende
Therapeutic targeting of viral RNAs: High-hanging fruit only needs a longer ladder
Stuart F J Le Grice
Sunil Poudel, Suresh Prajapati, Buddha Laxmi Prajapati, Rama Gyawali, Swosti Acharya, Binod Kumar Yadav and Bishnu Prasad Uppadhya
Tigist Bacha1, Birkneh Tilahun2 and Alemayehu Worku1
Soegeng Soegijanto, Oktavian Prasetia Wardana, Alpha Fardah Athiyyah, Budiono and Oedoyo Soedirham